Weekly Recap | Cue BioPharma -15.22%, clinical readout whipsawWeekly Review·Sep 26, 2026 at 06:09 AMCUE+11.21%
Weekly Recap | Cue BioPharma +4.74%, consensus target above spotWeekly Review·Sep 12, 2026 at 07:57 AMCUE+11.21%
